The EORTC QLU-C10D distinguished better between cancer patients and the general population than PROPr and EQ-5D-5L in a cross-sectional study

Health state utility (HSU) instruments for calculating quality-adjusted life years, such as the European Organisation for Research and Treatment of Cancer (EORTC) Quality of Life Utility - Core 10 Dimensions (QLU-C10D), derived from the EORTC QLQ-30 questionnaire, the Patient-Reported Outcome Measur...

Ausführliche Beschreibung

Bibliographische Detailangaben

Veröffentlicht in:	Journal of clinical epidemiology 2025-01, Vol.177, p.111592, Article 111592
Hauptverfasser:	Döhmen, Annika, Obbarius, Alexander, Kock, Milan, Nolte, Sandra, Sidey-Gibbons, Christopher J., Valderas, José M., Rohde, Jens, Rieger, Kathrin, Fischer, Felix, Keilholz, Ulrich, Rose, Matthias, Klapproth, Christoph Paul
Format:	Artikel
Sprache:	eng
Schlagworte:	Cancer Chemotherapy EORTC QLQ-C30 EQ-5D-5L Health-related quality of life Patient reported outcomes PROMIS-29 PROPr QLU-C10D
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!